References
- Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588.
- Javle M, Lee S, Azad NS, et al. Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017. Oncologist. 2022;27(10):874–883.
- Wadhwa V, Jobanputra Y, Thota PN, et al. Healthcare utilization and costs associated with cholangiocarcinoma. Gastroenterol Rep. 2017;5(3):213–218.
- Chamberlain CX, Faust E, Goldschmidt D, et al. Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis. J Gastrointest Oncol. 2021;12(2):658–668.
- IBM Corporation. IBM MarketScan research databases [Internet]. Armonk (NY): IBM Corporation; 2021 [cited 2022 Mar 31]. Available from: https://www.ibm.com/products/marketscan-research-databases/databases
- IBM Corporation. IBM MarketScan research databases for life sciences researchers [Internet]. Somers (NY): IBM Corporation; 2021 [cited 2022 Mar 31]. Available from: https://www.ibm.com/downloads/cas/OWZWJ0QO
- United States Census Bureau. Annual social and economic supplements; current population survey, 2019 annual social and economic (ASEC) supplement conducted by the Bureau of the Census for the Bureau of Labor Statistics [Internet]. Washington (SC): U.S. Census Bureau; 2019 [cited 2022 Mar 30]. Available from: https://www2.census.gov/programs-surveys/cps/techdocs/cpsmar19.pdf
- Hill DB. Employer-sponsored long-term disability insurance. Monthly Lab Rev. 1987;110:16–22.
- U.S. Bureau of Labor Statistics. Consumer price index [Internet]. Washington (DC): U.S. Bureau of Labor Statistics; 2020 [cited 2022 Mar 30]. Available from: https://www.bls.gov/news.release/archives/cpi_01142020.htm
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): hepatobiliary cancers. NCCN; 2022 [cited 2022 Jun 24]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1438
- Sarcognato S, Sacchi D, Fassan M, et al. Cholangiocarcinoma. Pathologica. 2021;113(3):158–169.
- Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(9):512–522.
- Lang K, Danchenko N, Gondek K, et al. The burden of illness associated with hepatocellular carcinoma in the United States. J Hepatol. 2009;50(1):89–99.
- U.S. Official Inflation Data Alioth Finance. $7,845 in 2006 is worth $9,948.58 in 2019 [Internet]. San Mateo (CA): Official Data Foundation; 2022 [cited 2022 May 10]. Available from: https://www.officialdata.org/us/inflation/2006?endYear=2019&amount=7845
- Patel N, Lie X, Gwaltney C, et al. Understanding patient experience in biliary tract cancer: a qualitative patient interview study. Oncol Ther. 2021;9(2):557–573.
- Hunter LA, Soares HP. Quality of life and symptom management in advanced biliary tract cancers. Cancers. 2021;13(20):5074.
- US Bureau of Labor Statistics. Paid sick leave was available to 79 percent of civilian workers in March 2021 [Internet]. Washington (DC): U.S. Bureau of Labor Statistics; 2021 [cited 2022 May 10]. Available from: https://www.bls.gov/opub/ted/2021/paid-sick-leave-was-available-to-79-percent-of-civilian-workers-in-march-2021.htm
- US Census Bureau. Current population survey, 2020 annual social and economic supplement (CPS ASEC): percentage of people by type of health insurance coverage: 2019 [Internet]. Washington (DC): US Census Bureau; 2020 [cited 2022 May 11]. Available from: https://www.census.gov/content/dam/Census/library/visualizations/2020/demo/p60-271/figure1.pdf